2024
Investigating Brain State Engagement Variability in Individuals With Opioid Use Disorder Using Naturalistic and Task-Based fMRI Data
Ye J, Mehta S, Peterson H, Ibrahim A, Saeed G, Linsky S, Kreinin I, Tsang S, Nwanaji-Enwerem U, Raso A, Yip S, Tokoglu F, Arora J, Constable R, Barry D, Redeker N, Yaggi H, Scheinost D. Investigating Brain State Engagement Variability in Individuals With Opioid Use Disorder Using Naturalistic and Task-Based fMRI Data. Biological Psychiatry 2024, 95: s6. DOI: 10.1016/j.biopsych.2024.02.022.Peer-Reviewed Original ResearchExperiences of Stigma and Discrimination Compounded by Intersecting Identities among Individuals Receiving Medication for Opioid Use Disorder.
Nwanaji-Enwerem U, Redeker N, O'Connell M, Barry D, Iheanacho T, Knobf T, Scheinost D, Wang K, Yaggi K, Sadler L. Experiences of Stigma and Discrimination Compounded by Intersecting Identities among Individuals Receiving Medication for Opioid Use Disorder. Journal Of Health Care For The Poor And Underserved 2024, 35: 94-115. PMID: 38661862, DOI: 10.1353/hpu.2024.a919810.Peer-Reviewed Original ResearchOpioid use disorderExperiences of stigmaIndividuals experience stigmaMarginalized social positionsIdentity of peopleUse disorderIntersectional identitiesMarginalized identitiesSupport interventionsSocial positionQualitative findingsStigmaNegative experiencesNortheast United StatesUnited StatesImprove outcomesIdentityTreatment centersMOUDIndividual vulnerabilityMedicationPeopleDiscriminationIndividuals
2023
Correlates of Perceived Discrimination Related to Substance Use Disorders Among Patients in Methadone Maintenance Treatment
Nwanaji-Enwerem U, Beitel M, Oberleitner D, Gazzola M, Eggert K, Oberleitner L, Jegede O, Zheng X, Redeker N, Madden L, Barry D. Correlates of Perceived Discrimination Related to Substance Use Disorders Among Patients in Methadone Maintenance Treatment. Journal Of Psychoactive Drugs 2023, 56: 530-540. PMID: 37399330, PMCID: PMC10761588, DOI: 10.1080/02791072.2023.2230571.Peer-Reviewed Original ResearchMethadone maintenance treatmentSubstance use disordersLogistic regression modelsUse disordersMaintenance treatmentTreatment-related characteristicsOpioid use disorderFinal logistic regression modelBSI-18 depressionAge of onsetRegression modelsMMT programDepressive symptomsMeasures of demographicsPatientsBivariate analysisSubstance abuseSignificant correlatesDisordersCorrelatesMedian splitAgeParticipantsTreatmentLikert-type scale0144 A Mixed Methods Exploration of Stigma, Discrimination, and Sleep among Individuals on Medication for Opioid Use Disorder
Nwanaji-Enwerem U, Sadler L, Jeon S, Barry D, Yaggi H, Redeker N. 0144 A Mixed Methods Exploration of Stigma, Discrimination, and Sleep among Individuals on Medication for Opioid Use Disorder. Sleep 2023, 46: a65-a65. DOI: 10.1093/sleep/zsad077.0144.Peer-Reviewed Original ResearchOpioid use disorderUse disordersInsomnia severitySpearman correlationInsomnia Severity IndexSleep studiesExperience symptomsSleep outcomesExperiences of stigmaLarge diverse sampleStigma ScaleInsomniaChronic stressorsSeverity IndexSleepMedicationsConclusions FindingsOUDIntervention approachesNegative healthStigmatized populationsSeverityDisordersStigmaOutcomes
2020
Correlates of sleep quality and excessive daytime sleepiness in people with opioid use disorder receiving methadone treatment
Baldassarri SR, Beitel M, Zinchuk A, Redeker NS, Oberleitner DE, Oberleitner LMS, Carrasco D, Madden LM, Lipkind N, Fiellin DA, Bastian LA, Chen K, Yaggi HK, Barry DT. Correlates of sleep quality and excessive daytime sleepiness in people with opioid use disorder receiving methadone treatment. Sleep And Breathing 2020, 24: 1729-1737. PMID: 32556918, PMCID: PMC7680294, DOI: 10.1007/s11325-020-02123-z.Peer-Reviewed Original ResearchConceptsOpioid use disorderExcessive daytime sleepinessDaytime sleepinessSleep qualityChronic painExcessive daytimeUse disordersConclusionsPoor sleep qualityCurrent chronic painModifiable risk factorsImpaired sleep qualityMultivariable linear regression modelsBody mass indexPoor sleep qualityNon-significant associationMass indexMultivariable analysisPain interferenceRelated comorbiditiesMethadone treatmentClinical correlatesMean PSQIRisk factorsSleep disordersResultsNinety percentOpioid use disorder research and the Council for the Advancement of Nursing Science priority areas
Eckardt P, Bailey D, DeVon HA, Dougherty C, Ginex P, Krause-Parello CA, Pickler RH, Richmond TS, Rivera E, Roye CF, Redeker N. Opioid use disorder research and the Council for the Advancement of Nursing Science priority areas. Nursing Outlook 2020, 68: 406-416. PMID: 32279897, PMCID: PMC7484386, DOI: 10.1016/j.outlook.2020.02.001.Peer-Reviewed Original Research